Skip to main content
OpenTrials
Completed

NCT Number: NCT00282204

Hypnosis Antenatal Training for Childbirth (HATCh): a Randomised Controlled Trial

Antenatal hypnosis is associated with a reduced need for pharmacological interventions during childbirth. This trial seeks to determine the efficacy or otherwise of antenatal group hypnosis preparation for childbirth in late pregnancy.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

Female

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

Women's and Children's Hospital

Adelaide, South Australia, 5006, Australia

About this study

Background: Although medical interventions play an important role in preserving lives and maternal comfort they have become increasingly routine in normal childbirth. This may increase the risk of associated complications and a less satisfactory birth experience. Antenatal hypnosis is associated with a reduced need for pharmacological interventions during childbirth. This trial seeks to determine the efficacy or otherwise of antenatal group hypnosis preparation for childbirth in late pregnancy.

Methods / Design: A single centre, randomised controlled trial using a 3 arm parallel group design in the largest tertiary maternity unit in South Australia. Group 1 participants receive antenatal hypnosis training in preparation for childbirth administered by a qualified hypnotherapist with the use of an audio compact disc on hypnosis for re-enforcement; Group 2 consists of antenatal hypnosis training in preparation for childbirth using an audio compact disc on hypnosis administered by a nurse with no training in hypnotherapy; Group 3 participants continue with their usual preparation for childbirth with no additional intervention. Women > 34 < 39 weeks gestation, with a singleton, viable fetus, vertex presentation, who are not in active labour or planning a vaginal birth are eligible to participate. Allocation concealment is achieved using telephone randomisation. Participants assigned to hypnosis groups are trained as near as possible to 37 weeks gestation. Group allocations are concealed from treating obstetricians, anaesthetists, midwives and those personnel collecting and analysing data. Our sample size of 135 women / group gives the study 80% power to detect a clinically relevant fall of 20% in the number of women requiring pharmacological analgesia - the primary endpoint. We estimate that approximately 5-10% of women will deliver prior to receiving their allocated intervention. We plan to recruit 150 women / group and perform interim analyses when 150 and 300 participants have been recruited. All participants will be analysed according to the "Intention to treat" principle with comprehensive pre-planned cost- benefit and subgroup analyses.

Discussion: If effective, hypnosis would be a simple, inexpensive way to improve the childbirth experience, reduce complications associated with pharmacological interventions, yield cost savings in maternity care, and provide evidence to guide clinical practice.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • women > 34 < 39 weeks gestation; singleton, viable fetus, vertex presentation, who are not in active labour (active labour is defined as cervical effacement and dilatation associated with regular uterine contractions) and who are planning a vaginal birth.

Exclusion criteria

  • Previous hypnosis preparation for childbirth;
  • poor understanding of English requiring translator;
  • women who are already enrolled in another pregnancy trial where analgesia requirements are an outcome measure;
  • active psychological or psychiatric problems such as: active depression requiring treatment by a psychiatrist;
  • schizophrenia;
  • prior psychosis;
  • severe intellectual disability.
  • Women with pain caused by specific pathological entities such as: congenital neuromuscular disorders; spina bifida; metastatic disease; osteoporosis; rheumatoid arthritis; fractures,are also excluded

Treatment and study plan

antenatal hypnosis + audio compact disc on hypnosis

Behavioral

Audio compact disc on hypnosis

Behavioral

Primary outcomes

  1. The use of pharmacological analgesia during labour and childbirth will be collected from the birth register where all analgesia is documented by the attending midwife

    Time frame: Within 24 hours of the birth

Secondary outcomes

  1. 1. Maternal rating of the overall pain experienced during labour and childbirth

    Time frame: Usually within 48 hours or before discharge from hospital

  2. 2. Mode of delivery

    Time frame: Within 24 hours of the birth

  3. 3. Use of oxytocics

    Time frame: Within 24 hours of the birth

  4. 4. Postnatal depression

    Time frame: At 6 weeks and 6 months postnatal

  5. 5. Maternal anxiety

    Time frame: At 6 weeks and 6 months postnatal

  6. 6. Neonatal Apgar score at 5 minutes < 7

    Time frame: within 24 hours of birth

  7. 7. Maternal admission to the High Dependency Unit (HDU) or the Intensive Care Unit (ICU)

    Time frame: within 24 hours of birth

  8. 8. Maternal rating whether the birth experience was. Worse / better / same as expected

    Time frame: within 24 hours of birth

  9. 9. Maternal rating of control during the labour during the birth

    Time frame: within 24 hours of birth

  10. 10. Maternal rating whether the birth was rated positive or negative experience

    Time frame: within 24 hours of birth

  11. 11. Length of neonatal nursery stay

    Time frame: within 24 hours of birth

  12. 12. Length of maternal stay in hospital

    Time frame: within 6 months of the birth

  13. 13. Number of women breast feeding at discharge from hospital and at 6 weeks and 6 months

    Time frame: 6 months after birth

Sponsors and collaborators

Lead sponsor

Women's and Children's Hospital, Australia

Other Gov

Registry information

Important dates

Study start
2005
Primary completion
2010
Study completion
2010
First posted
Jan 25, 2006
Registry last updated
Jun 29, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.